Invention Grant
US07972612B2 Remedy for glaucoma comprising Rho kinase inhibitor and β-blocker
有权
治疗包括Rho激酶抑制剂和β-阻断剂的青光眼
- Patent Title: Remedy for glaucoma comprising Rho kinase inhibitor and β-blocker
- Patent Title (中): 治疗包括Rho激酶抑制剂和β-阻断剂的青光眼
-
Application No.: US10535000Application Date: 2003-11-17
-
Publication No.: US07972612B2Publication Date: 2011-07-05
- Inventor: Masakazu Hatano , Tadashi Nakajima , Takeshi Matsugi , Hideaki Hara
- Applicant: Masakazu Hatano , Tadashi Nakajima , Takeshi Matsugi , Hideaki Hara
- Applicant Address: JP Osaka-Shi, Osaka
- Assignee: Santen Pharmaceutical Co., Ltd.
- Current Assignee: Santen Pharmaceutical Co., Ltd.
- Current Assignee Address: JP Osaka-Shi, Osaka
- Agency: Holtz, Holtz, Goodman & Chick, P.C.
- Priority: JP2002-333213 20021118
- International Application: PCT/JP03/14559 WO 20031117
- International Announcement: WO2004/045644 WO 20040603
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K31/535 ; A61K31/44
Abstract:
A subject of the present invention is to find utility of a combination of a Rho kinase inhibitor having a novel action and a β-blocker as a therapeutic agent for glaucoma. Actions of reducing intraocular pressure are complemented and/or enhanced each other by combining the Rho kinase inhibitor with the β-blocker. For the administration mode, each drug can be administered in combination or in mixture.
Public/Granted literature
- US20060052367A1 Remedy for glaucoma comprising rho kinase inhibitor and beta-blocker Public/Granted day:2006-03-09
Information query
